| |
 |
|
|
|
|
| Kyowa Hakko Kogyo, Janssen Pharmaceutical to End Distribution Partnership for Itrizole Capsule |
|
|
|
Tokyo, Feb 24, 2005 (JCN) - Kyowa Hakko Kogyo (TSE: 4151) has announced that it will dissolve a distribution partnership with Janssen Pharmaceutical for Itrizole Capsule, an oral antimycological agent, as of the end of March.
Since 1993, the two companies have been jointly promoting Itrizole. This dissolution is due to the expiration of the agreement term.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
Kyowa Hakko Bio to Commerciallize cis-4-Hydroxy-L-proline, Amino Acid Derivative
(May 13, 2011)
|
|
|
Kyowa Hakko to Develop Cancer Drug with Aussie Firm
(Apr 24, 2008)
|
|
|
Kyowa Hakko Licenses Anticancer Agent KW-2401 to Keryx Biopharmaceuticals
(Oct 4, 2006)
|
|
|
Kyowa Hakko's Original Anticancer Agent KW-2401(UCN-01) is Licensed to Keryx Biopharmaceuticals
(Oct 4, 2006)
|
|
|
Kyowa Hakko Develops World's First Fermentation-based Commercial Production Method for L-Tyrosine
(Sept 26, 2006)
|
|
|
Kyowa Hakko Develops World's First Commercial Production Method for L-Tyrosine Based on Fermentation; Successful Mass Production of L-Tyrosine from Non-Animal Sources
(Sept 26, 2006)
|
|
|
Alcon Japan, Kyowa Hakko Kogyo to Join Hands in Sales and Promotion of Olopatadine Hydrochloride Ophthalmic Solution
(June 29, 2006)
|
|
|
Kyowa Hakko Kogyo to Expand Its Fuji Plant and Accelerate R&D for Antibody Drugs
(June 23, 2006)
|
|
|
Kyowa Hakko Kogyo to Expand Its Fuji Plant and Accelerate R&D for Antibody Drugs
(June 23, 2006)
|
|
|
Meiji Dairies, Kyowa Hakko Kogyo Receive Approval for MRI Digestive Tract Contrast Medium BOTHDEL
(Apr 26, 2006)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
|
|
|
|
